Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)

v3.24.1.1.u2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2024
USD ($)
shares
Dec. 31, 2023
USD ($)
shares
Mar. 31, 2024
£ / shares
Dec. 31, 2023
£ / shares
CONDENSED CONSOLIDATED BALANCE SHEETS        
Marketable securities - amortized cost $ 2,981 $ 2,940    
Marketable securities - Net of allowance for expected credit losses 0 0    
Allowance for expected credit losses 0 0    
Operating lease right-of-use assets, accumulated amortization 14,381 13,220    
Property, plant and equipment, accumulated depreciation 48,445 46,020    
Intangibles, accumulated amortization $ 5,198 $ 5,155    
Common stock, par value | £ / shares     £ 0.001 £ 0.001
Common stock, shares authorized | shares 1,702,760,280 1,702,760,280    
Common stock, shares issued | shares 1,532,974,878 1,363,008,102    
Common stock, shares outstanding | shares 1,532,974,878 1,363,008,102